Affiliation:
1. Department of Pharmacy Yale‐New Haven Hospital New Haven Connecticut USA
2. Department of Internal Medicine, Infectious Disease Section Yale‐New Haven Hospital New Haven Connecticut USA
3. Department of Section of Infectious Diseases, Department of Internal Medicine Yale School of Medicine New Haven Connecticut USA
Abstract
AbstractLiposomal amphotericin B (LAmB) is used in the treatment of opportunistic fungal and parasitic infections, including leishmaniasis. Given its lack of known teratogenicity in pregnancy, LAmB is a preferred agent for treatment for these patients. However, significant gaps remain in determining optimal dosing regimens for LAmB in pregnancy. We describe the use of LAmB for a pregnant patient with mucocutaneous leishmaniasis (MCL) using a dosing strategy of 5 mg/kg/day for days 1–7 using ideal body weight followed by 4 mg/kg weekly using adjusted body weight. We reviewed the literature for LAmB dosing strategies, particularly dosing weight, in pregnancy. Of the 143 cases identified in 17 studies, only one reported a dosing weight, in which ideal body weight was used. Five Infectious Diseases Society of America guidelines in total discussed the use of amphotericin B in pregnancy but no guidelines included recommendations for dosing weight. This review describes our experience in using ideal body weight for dosing LAmB in pregnancy for the treatment of MCL. Use of ideal body weight may minimize risk of adverse effects to the fetus compared to the use of total body weight while maintaining efficacy for treatment of MCL in pregnancy.
Reference67 articles.
1. A General Classification of New World Leishmania Using Numerical Zymotaxonomy
2. Is it time to revise the nomenclature of Leishmania?
3. Prevention CC for DC and CDC ‐ Leishmaniasis ‐ Resources for Health Professionals. July 5 2022. Accessed July 20 2022.https://www.cdc.gov/parasites/leishmaniasis/health_professionals/index.html
4. World Health Organization.Leishmaniasis. Weekly epidemiological record No 22. 2016. Accessed July 20 2022.https://www.who.int/health‐topics/leishmaniasis
5. Mucosal Leishmaniasis: An Underestimated Presentation of a Neglected Disease
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comment on “Dosing implications for liposomal amphotericin B in pregnancy”;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-09